Robert Baumgartner V - 30 Oct 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Nov 2025, 17:22:31 UTC
Prior SEC filing
27 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.

Key filing fact

Robert Baumgartner V filed Form 4 for BIO-TECHNE Corp (TECH) on 03 Nov 2025.

Key facts

  • This page summarizes Robert Baumgartner V's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 2 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2025, 17:22.

Change

  • Previous filing in this sequence was filed on 27 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258704 Primary reporting owner

BAUMGARTNER ROBERT V

Relationship
Director
Address
614 MCKINLEY PL NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Signature date
03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Award

Transaction value
$0
Shares
+1,640
Change %
+3.7%
Price
$0.000000
Shares after
46,503
Date
30 Oct 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+3,777
Change %
Price
$0.000000
Shares after
3,777
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,777
Exercise price
$60.96
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,940
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,940
Exercise price
$25.30
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,500
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$31.26
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,592
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,592
Exercise price
$44.96
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,044
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,044
Exercise price
$50.41
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,028
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,028
Exercise price
$63.92
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,532
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,532
Exercise price
$128.81
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,460
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,460
Exercise price
$73.94
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,937
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,937
Exercise price
$61.51
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,511
Date
30 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,511
Exercise price
$68.37
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .